Form 4: IGM Biosciences Director Acquires Shares as Part of Compensation Policy

Jakob Haldor Topsoe, a director of IGM Biosciences, acquired 1,734 shares of common stock as part of the company's Outside Director Compensation Policy.

Summary

• On June 28, 2024, Jakob Haldor Topsoe, a director of IGM Biosciences, acquired 1,734 shares of common stock.
• The acquisition was part of a quarterly retainer paid in common stock according to the Issuer's Outside Director Compensation Policy.
• The shares were acquired at a price of $0.
• Following the transaction, Topsoe directly owns 86,588 shares of IGM Biosciences common stock.
• Topsoe also indirectly owns 10,400,564 shares through Topsoe Holding A/S, where he and other board members may be deemed to share voting and investment power.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The director's share acquisition is a routine part of their compensation and signals confidence in the company, but it's not a major event.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The use of stock as part of the director's compensation aligns the director's interests with those of the shareholders.

Industry Context

Director share acquisitions are common and often viewed positively as they align management's interests with shareholders. This transaction is part of a pre-defined compensation policy, making it a routine event.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the director's increased stake in the company.

Key Dates